Orange Health Targets Profitability by Early 2028 Amid Expansion Plans
Indian diagnostic services chain Orange Health aims to achieve profitability by early 2028 as it expands operations and strengthens its at-home testing network.
Akanksha jain 
["company", "Orange Health", "Indian diagnostic startup"], an Indian diagnostic services chain, is aiming to achieve, according to a report by ["organization", "Reuters", "international news agency"].
The company focuses on at-home sample collection and presence in key urban markets while optimizing operational efficiency.
Growth Strategy:
Orange Health has positioned itself within India’s growing diagnostics sector by offering doorstep sample collection and digital-first service models. The company plans to expand into additional cities and invest in laboratory infrastructure to support rising demand.
Industry analysts note that India’s diagnostic services market has seen strong growth driven by increased health awareness, preventive testing trends, and post-pandemic demand for accessible healthcare services.
Path to Profitability:
To reach profitability by early 2028, the company is focusing on improving margins through scale, cost optimization, and enhanced customer retention. Executives have indicated that sustained revenue growth and operational discipline will be key to meeting financial targets.
The firm is also navigating competitive pressures from established diagnostic chains and emerging startups within the sector.
Sector Outlook:
India’s healthcare and diagnostics market continues to attract investor interest, supported by rising disposable incomes and digital health adoption. Companies offering convenience-driven models, such as home-based testing, are expected to play a significant role in shaping the industry’s evolution.
If Orange Health meets its projected timeline, it could strengthen its standing in a rapidly expanding and increasingly competitive diagnostics landscape.
